Siga Technologies Inc. (SIGA, Financial) experienced a significant stock price decline of 5.01%, trading at $5.79 per share with a trading volume of 167,629 shares and a turnover rate of 0.23%. The stock's amplitude reached 6.81%. Recent financial reports show the company achieved revenue of $10.01 million, net profit of $1.34 million, and earnings per share of $0.02, with a gross profit of $8.39 million and a price-to-earnings ratio of 4.86. Currently, no institutional ratings are available for SIGA.
Within the pharmaceutical industry, the overall decline was 1.40%. Notable performers included Scilex Holding Company and Procaps Group S.A., while active stocks like Petros Pharmaceuticals, Inc. and Quantum Biopharma Ltd. showed high turnover rates. Siga Technologies focuses on health security, primarily offering TPOXX, an oral antiviral for smallpox treatment, with major revenue from the U.S.
